Network Pharmacology Combined With Experimental Validation Reveals the Mechanism of Action of Megacarpaea delavayi on L-arginine-Induced Functional Dyspepsia
International Journal of Pharmacology · 12.05.2026 · 22 (3)
DOI: 10.31083/ijp48017 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacology, online erschienen am 12.05.2026. Verfasst von Liqi Cang und 6 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to evaluate the therapeutic effect of Megacarpaea delavayi (M. delavayi) on L-arginine (L-arg)-induced functional dyspepsia (FD) and to elucidate the associated underlying mechanisms using network pharmacology and in vivo experiments.
Methods
A mouse model of L-arg-induced FD was established to assess the efficacy of M. delavayi. Subsequently, network pharmacology analysis was employed to predict potential candidate targets and signaling pathways of M. delavayi. Finally, the candidate targets were assessed in the mouse model described above.
Results
M. delavayi promoted gastrointestinal peristalsis, reduced gastric tissue damage, increased serum levels of motilin (MTL) and gastrin (GAS), and decreased acetylcholinesterase (AChE) level in FD mice. Network pharmacology analysis identified 102 overlapping targets at the intersection of M. delavayi-related compounds and FD-associated genes. Protein-protein interaction (PPI) network analysis identified inflammation-associated targets, including interleukin-6 (IL6), tumor necrosis factor (TNF), nitric oxide synthase 1 (NOS1), epidermal growth factor receptor (EGFR), SRC proto-oncogene (SRC), and signal transducer and activator of transcription 3 (STAT3). Integration of these targets with functional and pathway enrichment analyses revealed that nitric oxide (NO) and related inflammatory signaling pathways play a pivotal role in the pharmacological effects of M. delavayi. Validation in FD mice further demonstrated that M. delavayi decreased O₂⁻ contents and restored the impaired NO-soluble guanylate cyclase (sGC)-protein kinase G (PKG) signaling pathway by elevating the levels of neuronal nitric oxide synthase (nNOS), sGC and PKG. Conversely, an increase in inducible nitric oxide synthase (iNOS) expression was also observed.
Conclusion
M. delavayi effectively ameliorates L-arg-induced gastrointestinal dysfunction through restoration of the NO-sGC-PKG signaling pathway.
Zitieren
APA
Cang, L., Deng, Z., Wang, H., Zhou, J., Wang, J., Jiang, B., & Shen, L. (2026). Network Pharmacology Combined With Experimental Validation Reveals the Mechanism of Action of Megacarpaea delavayi on L-arginine-Induced Functional Dyspepsia. International Journal of Pharmacology, 22(3). https://doi.org/10.31083/ijp48017
Vancouver
Cang L, Deng Z, Wang H, Zhou J, Wang J, Jiang B, et al. Network Pharmacology Combined With Experimental Validation Reveals the Mechanism of Action of Megacarpaea delavayi on L-arginine-Induced Functional Dyspepsia. International Journal of Pharmacology. 2026;22(3). doi:10.31083/ijp48017
BibTeX
@article{Cang2026,
author = {Cang, Liqi and Deng, Zhongyang and Wang, Hangrao and Zhou, Jie and Wang, Jinda and Jiang, Bei and Shen, Lei},
title = {Network Pharmacology Combined With Experimental Validation Reveals the Mechanism of Action of Megacarpaea delavayi on L-arginine-Induced Functional Dyspepsia},
journal = {International Journal of Pharmacology},
year = {2026},
volume = {22},
number = {3},
doi = {10.31083/ijp48017}
}
EUVIMED